ZAI LAB LIMITED

ZLAB ·Healthcare, Drug Manufacturers - General
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Dec 2020 Dec 2019
Assets
Cash & Equivalents $680.8M $847.0M $964.1M $1.40B $1.77B $1.01B $442.1M $75.9M
Accounts Receivable $27.1M $33.4M $47.5M $21.0M $18.0M $8.8M $5.2M $3.8M
Inventory $23.3M $20.3M $19.0M $12.5M $11.1M $12.6M $13.1M $6.0M
Total Current Assets $1.34B $1.39B $1.50B $1.62B $1.81B $1.05B $1.22B $292.5M
Property, Plant & Equipment $46.4M $45.2M $43.1M $37.1M $31.6M $29.0M $29.2M $21.4M
Goodwill
Intangible Assets (Excl. Goodwill) $1.7M $1.7M $1.8M $1.7M $1.7M $1.6M $1.5M $1.1M
Total Assets $1.42B $1.50B $1.61B $1.73B $1.90B $1.13B $1.30B $355.2M
Liabilities
Accounts Payable $108.4M $98.2M $126.2M $51.4M $125.6M $41.4M $62.6M $22.7M
Total Current Liabilities $168.9M $154.9M $192.9M $112.0M $193.9M $92.7M $98.0M $46.6M
Long-Term Debt
Total Liabilities $206.6M $192.9M $230.0M $140.1M $223.5M $121.6M $128.3M $60.5M
Stockholders' Equity
Retained Earnings $-1.64B $-1.50B $-1.42B $-1.21B $-1.11B $-946.5M $-713.6M $-444.7M
Total Stockholders' Equity $1.21B $1.31B $1.38B $1.59B $1.67B $1.01B $1.17B $294.7M
← Newer Page 3 of 3 Older →